On November 4, 2003, a health care provider gave Jon Gluck a few of the worst information possible: He had most cancers — one which later assessments would reveal as a number of myeloma, a extreme blood and bone marrow most cancers.
Jon was advised he might need as little as 18 months to reside. He was 38, a thriving journal editor in New York with a 7-month-old daughter whose third birthday, he abruptly realized, he would possibly by no means see.
“The second after I used to be advised I had most cancers, I simply mentioned ‘no, no, no,’” Jon advised me in an interview simply final week. “This can’t be true.”
The truth that Jon continues to be right here, speaking to me in 2025, tells you that issues didn’t go the way in which the medical knowledge would have predicted on that November morning. He has lived together with his most cancers, by waves of remission and recurrence, for greater than 20 years, an expertise he chronicles with grace and wit in his new e book An Train in Uncertainty. That 7-month-old daughter is now in school.
You might say Jon has overwhelmed the chances, and he’s effectively conscious that likelihood performed some position in his survival. (“Do you know that ‘Glück’ is German for ‘luck’?” he writes within the e book, noting his luck {that a} random spill on the ice is what despatched him to the physician within the first place, enabling them to catch his most cancers early.) Most cancers continues to be a horrible well being menace, one that’s answerable for 1 in 6 deaths all over the world, killing practically 10 million individuals a yr globally and over 600,000 individuals a yr within the US.
However Jon’s story and his survival reveal one thing that’s too typically missed: We’ve turned the tide within the conflict towards most cancers.
The age-adjusted dying charge within the US for most cancers has declined by a few third since 1991, that means individuals of a given age have a few third decrease threat of dying from most cancers than individuals of the identical age greater than three many years in the past. That provides as much as over 4 million fewer most cancers deaths over that point interval. Due to breakthroughs in therapies like autologous stem-cell harvesting and CAR-T remedy — breakthroughs Jon himself benefited from, typically simply in time — most cancers isn’t the dying sentence it as soon as was.
Our World in Knowledge
Getting higher on a regular basis
There’s little doubt that simply because the rise of smoking within the Twentieth century led to a serious improve in most cancers deaths, the equally sharp decline of tobacco use finally led to a delayed lower. Smoking is some of the potent carcinogens on the earth, and on the peak within the early Sixties, round 12 cigarettes have been being bought per grownup per day within the US. Take away the cigarettes and — after a delay of a few many years — lung most cancers deaths drop in flip together with different non-cancer smoking-related deaths.
However as Saloni Dattani wrote in an excellent piece earlier this yr, even earlier than the decline of smoking, dying charges from non-lung cancers within the abdomen and colon had begun to fall. Simply as notably, dying charges for childhood cancers — which for apparent causes aren’t related to smoking and are typically attributable to genetic mutations — have fallen considerably as effectively, declining sixfold since 1950. Within the Sixties, for instance, solely round 10 % of kids identified with acute lymphoblastic leukemia survived greater than 5 years. At the moment it’s greater than 90 %. And the five-year survival charge for all cancers has risen from 49 % within the mid-Nineteen Seventies to 69 % in 2019.
We’ve made strikes towards the hardest of cancers, like Jon’s a number of myeloma. Round when Jon was identified, the five-year survival charge was simply 34 %. At the moment it’s as excessive as 62 %, and an increasing number of individuals like Jon reside for many years. “There was a revolution in most cancers survival,” Jon advised me. “Some sicknesses now have way more profitable therapies than others, however the positive factors are actual.”
The dramatic bend within the curve of most cancers deaths didn’t occur accidentally — it’s the compound curiosity of three revolutions.
Whereas anti-smoking coverage has been the one largest lifesaver, different interventions have helped cut back individuals’s most cancers threat. One of many largest successes is the HPV vaccine. A examine final yr discovered that dying charges of cervical most cancers — which could be attributable to HPV infections — in US girls ages 20–39 had dropped 62 % from 2012 to 2021, thanks largely to the unfold of the vaccine. Different cancers have been linked to infections, and there’s sturdy analysis indicating that vaccination can have optimistic results on lowering most cancers incidence.
The following revolution is best and earlier screening. It’s typically true that the sooner most cancers is caught, the higher the probabilities of survival, as Jon’s personal story exhibits. In response to one examine, incidences of late-stage colorectal most cancers in People over 50 declined by a 3rd between 2000 and 2010 largely as a result of charges of colonoscopies nearly tripled in that very same time interval. And newer screening strategies, typically using AI or utilizing blood-based assessments, might make preliminary screening less complicated, much less invasive and subsequently extra available. If Twentieth-century screening was about discovering bodily proof of one thing fallacious — the lump within the breast — Twenty first-century screening goals to seek out most cancers earlier than signs even come up.
Most enjoyable of all are frontier developments in treating most cancers, a lot of which could be tracked by Jon’s personal expertise. From medication like lenalidomide and bortezomib within the 2000s, which helped double median myeloma survival, to the unfold of monoclonal antibodies, actual breakthroughs in therapies have meaningfully prolonged individuals’s lives — not simply by months, however years.
Maybe essentially the most promising growth is CAR-T remedy, a type of immunotherapy. Quite than making an attempt to kill the most cancers instantly, immunotherapies flip a affected person’s personal T-cells into guided missiles. In a latest examine of 97 sufferers with a number of myeloma, lots of whom have been going through hospice care, a 3rd of those that acquired CAR-T remedy had no detectable most cancers 5 years later. It was the form of end result that medical doctors not often see.
“CAR-T is mind-blowing — very science-fiction futuristic,” Jon advised me. He underwent his personal course of remedy with it in mid-2023 and writes that the expertise, which put his most cancers right into a remission he’s nonetheless in, left him feeling “bodily and metaphysically new.”
Whereas there are nonetheless extra battles to be gained within the conflict on most cancers, and there are specific areas — just like the rising charges of gastrointestinal cancers amongst youthful individuals — the place the story isn’t getting higher, the way forward for most cancers remedy is enhancing. For most cancers sufferers like Jon, that may imply a brand new problem — enduring the important uncertainty that comes with residing beneath a illness that’s controllable however which might at all times come again.
But it surely positive beats the choice.
“I’ve come to belief so utterly in my medical doctors and in these new developments,” he mentioned. “I attempt to stay cautiously optimistic that my future can be very similar to the final 20 years.” And that’s greater than he or anybody else might have hoped for practically 22 years in the past.
A model of this story initially appeared within the Good Information e-newsletter. Enroll right here!
